Another disadvantage is that antibodies typically exhibit long serum half-lives (often weeks) and therefore, drug action cannot be quickly removed/attenuated in situations (like infection) requiring the restoration of functional IL17 to resolve. This evidence concerns the gene IL17A and infection.